유바이오로직스: directors' dealings · South Korea · DART (FSS)

Explore the full insider trade history of 유바이오로직스, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 유바이오로직스 has published 5 public disclosures. Market capitalisation: €413.9bn. The latest transaction was reported on 3 April 2026 (Purchase). Among the most active insiders: 바이오노트. Every trade is free.